Modern Rheumatology

, Volume 23, Issue 4, pp 804–810 | Cite as

Fc receptor beta chain deficiency exacerbates murine arthritis in the anti-type II collagen antibody-induced experimental model

  • Mino Ohtsubo-Yoshioka
  • Satoshi Nunomura
  • Tatsuki R. Kataoka
  • Yoshimichi Okayama
  • Chisei RaEmail author
Original Article



Fc receptor β chain (FcRβ) acts as a signaling component of FcγRIII in immune cells such as mast cells (MCs) or basophils. Recent studies reported that FcγRIII contributes to the development of arthritic inflammation. These findings suggest that FcRβ may play a pivotal role in the pathogenesis of arthritic inflammation. To address this possibility, we examined the function of FcRβ in arthritic inflammation employing a mouse model.


For the induction of arthritis, we injected 2 mg of a cocktail of anti-type II collagen (CII) monoclonal antibodies (mAbs) into C57BL/6J mice (FcRβ+/+) and FcRβ−/− mice intravenously. Three days later, 100 μg lipopolysaccharide (LPS; Escherichia coli 055:B5) was intraperitoneally injected. Joint swelling was evaluated by inspection. Histopathology of joint tissues was examined by hematoxylin and eosin (H&E) or tartrate-resistant acid phosphatase staining.


Here, we demonstrate in a well-established experimental arthritis model induced by LPS and anti-CII mAbs that FcRβ−/− mice exhibit exacerbated arthritic inflammation manifested in paw swelling, leukocyte infiltration into the knee joint, and bone erosion and tissue cytokine expression.


Our findings clearly indicate that FcRβ negatively regulates arthritic inflammation in an experimental arthritis model.


Anti-CII mAb-induced arthritis Fc receptor Mast cell 



We thank Toyoharu Jike for his invaluable advice in histological experiments. This work was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology-Supported Program for the Strategic Research Foundation at Private Universities (to C.R.), Grant-in-Aid for Scientific Research B (KAKENHI22390202 to C.R.), and Young Scientists B (KAKENHI 23791124 to M.O.-Y., 20790699 to S.N.).

Conflict of interest

The authors report no conflict of interest.


  1. 1.
    Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell. 1996;85:307–10.PubMedCrossRefGoogle Scholar
  2. 2.
    Corr M, Crain B. The role of FcγR signaling in the K/BxN serum transfer model of arthritis. J Immunol. 2002;169:6604–9.PubMedGoogle Scholar
  3. 3.
    Mancardi DA, Jonsson F, Iannascoli B, Khun H, Van Rooijen N, Huerre M, et al. Cutting edge: the murine high-affinity IgG receptor FcγRIV is sufficient for autoantibody-induced arthritis. J Immunol. 2011;186:1899–903.PubMedCrossRefGoogle Scholar
  4. 4.
    Kagari T, Tanaka D, Doi H, Shimozato T. Essential role of Fcγ receptors in anti-type II collagen antibody-induced arthritis. J Immunol. 2003;170:4318–24.PubMedGoogle Scholar
  5. 5.
    Hiraoka S, Furumoto Y, Koseki H, Takagaki Y, Taniguchi M, Okumura K, et al. Fc receptor β subunit is required for full activation of mast cells through Fc receptor engagement. Int Immunol. 1999;11:199–207.PubMedCrossRefGoogle Scholar
  6. 6.
    Bromley M, Fisher WD, Woolley DE. Mast cells at sited of cartilage erosion in the rheumatoid joint. Ann Rheum Dis. 1984;43:76–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Nigrovic PA, Lee DM. Synovial mast cells: role in acute and chronic arthritis. Immunol Rev. 2007;217:19–37.PubMedCrossRefGoogle Scholar
  8. 8.
    Sawamukai N, Saito K, Yamaoka K, Nakayamada S, Ra C, Tanaka Y. Leflunomide inhibits PDK1/Akt pathway and induces apoptosis of human mast cells. J Immunol. 2007;179:6479–84.PubMedGoogle Scholar
  9. 9.
    Juurikivi A, Sandler C, Lindstedt KA, Kovanen PT, Juutilainen T, Leskinen MJ, et al. Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis. Ann Rheum Dis. 2005;64:1126–31.PubMedCrossRefGoogle Scholar
  10. 10.
    Kobayashi M, Nunomura S, Gon Y, Endo D, Kishiro S, Fukunaga M, et al. Abrogation of high-affinity IgE receptor-mediated mast cell activation at the effector phase prevents contact hypersensitivity to oxazolone. J Invest Dermatol. 2010;130:725–31.PubMedCrossRefGoogle Scholar
  11. 11.
    Zhou JS, Xing W, Friend DS, Austen KF, Katz HR. Mast cell deficiency in Kit(W-sh) mice does not impair antibody-mediated arthritis. J Exp Med. 2007;204:2797–802.PubMedCrossRefGoogle Scholar
  12. 12.
    Rittirsch D, Flierl MA, Day DE, Nadeau BA, Zetoune FS, Sarma JV, et al. Cross-talk between TLR4 and FcγReceptorIII (CD16) pathways. PLoS Pathog. 2009;5(6):e1000464.Google Scholar
  13. 13.
    Nimmerjahn F, Ravetch JV. Fc-receptors as regulators of immunity. Adv Immunol. 2007;96:179–204.PubMedCrossRefGoogle Scholar
  14. 14.
    Tanaka D, Kagari T, Doi H, Shimozato T. Essential role of neutrophils in anti-type II collagen antibody and lipopolysaccharide-induced arthritis. Immunology. 2006;119:195–202.Google Scholar
  15. 15.
    Joyce-Shaikh B, Bigler ME, Chao CC, Murphy EE, Blumenschein WM, Adamopoulos IE, et al. Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis. J Exp Med. 2010;207:579–89.PubMedCrossRefGoogle Scholar
  16. 16.
    Kagari T, Doi H, Shimozato T. The importance of IL-1β and TNF-α, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. J Immunol. 2002;169:1459–66.Google Scholar
  17. 17.
    Pettit AR, Ji H, von Stechow D, Muller R, Goldring SR, Choi YW, et al. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol. 2001;159:1689–99.PubMedCrossRefGoogle Scholar
  18. 18.
    Redlich K, Hayer S, Ricci R, David JP, Tohidast-Akrad M, Kollias G, et al. Osteoclasts are essential for TNF-α-mediated joint destruction. J Clin Invest. 2002;110:1419–27.PubMedGoogle Scholar
  19. 19.
    Theill LE, Boyle WJ, Penninger JM. RANK-L AND RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol. 2002;20:795–823.PubMedCrossRefGoogle Scholar
  20. 20.
    Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6. Proc Natl Acad Sci USA. 1993;90:11924–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Kurihara N, Bertolini D, Suda T, Akiyama Y, Roodman GD. IL-6 stimulates osteoclast-like multinucleated cell-formation in long-term human marrow cultures by inducing IL-1 release. J Immunol. 1990;144:4226–30.PubMedGoogle Scholar
  22. 22.
    Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423:337–42.PubMedCrossRefGoogle Scholar
  23. 23.
    Dombrowicz D, Quatannens B, Papin JP, Capron A, Capron M. Expression of a functional FcεRI on rat eosinophils and macrophages. J Immunol. 2000;165:1266–71.PubMedGoogle Scholar
  24. 24.
    Porcherie A, Mathieu C, Peronet R, Schneider E, Claver J, Commere PH, et al. Critical role of the neutrophil-associated high-affinity receptor for IgE in the pathogenesis of experimental cerebral malaria. J Exp Med. 2011;208:2225–36.PubMedCrossRefGoogle Scholar
  25. 25.
    Furumoto Y, Nunomura S, Terada T, Rivera J, Ra C. The FcεRIβ immunoreceptor tyrosine-based activation motif exerts inhibitory control on MAPK and IkappaB kinase phosphorylation and mast cell cytokine production. J Biol Chem. 2004;279:49177–87.PubMedCrossRefGoogle Scholar
  26. 26.
    Guma M, Kashiwakura J, Crain B, Kawakami Y, Beutler B, Firestein GS, et al. JNK1 controls mast cell degranulation and IL-1β production in inflammatory arthritis. Proc Natl Acad Sci USA. 2010;107:22122–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Nigrovic PA, Binstadt BA, Monach PA, Johnsen A, Gurish M, Iwakura Y, et al. Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1. Proc Natl Acad Sci USA. 2007;104:2325–30.PubMedCrossRefGoogle Scholar
  28. 28.
    Quinones MP, Ahuja SK, Jimenez F, Schaefer J, Garavito E, Rao A, et al. Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis. J Clin Invest. 2004;113(6):856–66.PubMedGoogle Scholar

Copyright information

© Japan College of Rheumatology 2012

Authors and Affiliations

  • Mino Ohtsubo-Yoshioka
    • 1
  • Satoshi Nunomura
    • 1
  • Tatsuki R. Kataoka
    • 2
  • Yoshimichi Okayama
    • 1
  • Chisei Ra
    • 1
    Email author
  1. 1.Division of Molecular Cell Immunology and Allergology, Department of Biomedical SciencesNihon University School of MedicineItabashi-kuJapan
  2. 2.Department of Diagnostic PathologyKyoto University HospitalKyotoJapan

Personalised recommendations